ABSTRACT
Inhalation of Yersinia pestis results in primary pneumonic plague, a highly lethal and rapidly progressing necrotizing pneumonia. The disease begins with a period of extensive bacterial replication in the absence of disease symptoms, followed by the sudden onset of inflammatory responses that ultimately prove fatal. Very little is known about the bacterial and host factors that contribute to the rapid biphasic progression of pneumonic plague. In this work, we analyzed the in vivo transcription kinetics of 288 bacterial open reading frames previously shown by microarray analysis to be dynamically regulated in the lung. Using this approach combined with bacterial genetics, we were able to identify five Y. pestis genes that contribute to the development of pneumonic plague. Deletion of one of these genes, ybtX, did not alter bacterial survival but attenuated host inflammatory responses during late-stage disease. Deletion of ybtX in another lethal respiratory pathogen, Klebsiella pneumoniae, also resulted in diminished host inflammation during infection. Thus, our in vivo transcriptional screen has identified an important inflammatory mediator that is common to two Gram-negative bacterial pathogens that cause severe pneumonia.
IMPORTANCE
Yersinia pestis is responsible for at least three major pandemics, most notably the Black Death of the Middle Ages. Due to its pandemic potential, ease of dissemination by aerosolization, and a history of its weaponization, Y. pestis is categorized by the Centers for Disease Control and Prevention as a tier 1 select agent most likely to be used as a biological weapon. To date, there is no licensed vaccine against Y. pestis. Importantly, an early “silent” phase followed by the rapid onset of nondescript influenza-like symptoms makes timely treatment of pneumonic plague difficult. A more detailed understanding of the bacterial and host factors that contribute to pathogenesis is essential to understanding the progression of pneumonic plague and developing or enhancing treatment options.
INTRODUCTION
Yersinia pestis is the causative agent of plague and one of the deadliest human pathogens. Primary pneumonic plague resulting from the inhalation of Y. pestis is the most severe manifestation of plague, with mortality rates approaching 100% in the absence of timely delivery of antibiotics (1). Its low infectious dose, capacity for aerosol transmission, and history of weaponization have led to the classification of Y. pestis as a tier 1 select agent requiring biosafety level 3 containment.
Our laboratory and others have characterized a mouse model of pneumonic plague using fully virulent Y. pestis that closely mimics human disease (2–5). Progression of pneumonic plague is biphasic, with an initial “preinflammatory” phase in the lung highlighted by a lack of disease symptoms or detectable host immune responses. After 36 to 48 h, there is an abrupt switch to a “proinflammatory” phase of disease characterized by the rapid onset of symptoms, induction of proinflammatory cytokines, and the dramatic accumulation of immune infiltrate in the airways. Progression into the proinflammatory phase of disease leads to the severe necrotizing pneumonia that is the hallmark of pneumonic plague and invariably proves fatal within the following 24 to 36 h. Little is known about the bacterial and host factors that contribute to the progression of this disease.
Previously, our laboratory used microarray analysis to identify 410 Y. pestis genes that were significantly up- or downregulated in the bronchoalveolar lavage fluid (BALF) of mice 48 h postinoculation (hpi) compared to broth-grown culture (5). This work gave insight into the dynamic bacterial gene expression that occurs in the lung during infection but is only a snapshot of the syndrome at a singular point during the proinflammatory disease phase. In the work presented here, we implemented an in vivo transcriptional screen to identify Y. pestis genes that contribute to the progression of pneumonic plague. By evaluating the expression kinetics of dynamically regulated bacterial genes in vivo and then generating corresponding deletion mutants, we were able to identify five genes that contribute to Y. pestis pathogenesis during pneumonic plague. Deletion of one gene, ybtX, had no effect on bacterial or host survival but completely altered progression into the proinflammatory phase of disease. Deletion of ybtX in Klebsiella pneumoniae, a pathogen that causes a similar necrotizing pneumonia, also reduced inflammation during lung infection, indicating that ybtX may be involved in the pathogenesis of severe bacterial pneumonia caused by multiple species of bacteria.
RESULTS
Transcriptional analysis of highly regulated Y. pestis genes during pulmonary infection.
In 2005, Lathem et al. identified 410 Y. pestis open reading frames (ORFs) that were significantly up- or downregulated in the bronchoalveolar lavage fluid of mice 48 h after intranasal inoculation with Y. pestis (5). Unfortunately, performing similar analysis at earlier time points proved technically difficult. We sought to use real-time quantitative reverse transcription PCR (qRT-PCR) to evaluate in detail the expression kinetics of highly regulated Y. pestis genes throughout the duration of infection. We hypothesized that this analysis would reveal open reading frames that are regulated in a phase-specific manner in the lung, as well as genes that are highly induced at multiple time points during infection. Phase-specific regulation or constitutive expression may indicate that these genes are important to the progression of pneumonic plague. After elimination of a number of metabolic genes and genes with well-defined functions, 288 Y. pestis ORFs were chosen from the previous 410 genes for further transcriptional profiling. To this end, total RNA was isolated from the lungs of mice infected with Y. pestis CO92 at 24, 36, 48, and 60 hpi and analyzed by qRT-PCR. Fold difference was calculated for each gene by comparing its expression to that of RNA isolated from broth-grown culture. We focused our attention on genes showing one of the following three patterns of transcription (Fig. 1A): (i) gene was upregulated greater than 5-fold during at least one of the early time points (24 h or 36 h) compared to the later time points (48 h or 60 h), (ii) gene was upregulated greater than 5-fold during at least one of the later time points compared to early time points, or (iii) gene was upregulated greater than 5-fold relative to broth-grown culture throughout the duration of infection. From this analysis, we identified 38 genes/loci of interest that we sought to target for further analysis (see Table S1 in the supplemental material).
FIG 1 .
Identifying genes important to pneumonic plague. (A) Examples of in vivo transcription patterns of interest. Lungs from mice (n = 10) infected with Y. pestis were harvested, and 288 ORFs were evaluated by qRT-PCR. Fold difference was calculated by comparing expression to RNA isolated from broth culture grown at 37°C for 16 h. (B) Lung bacterial burdens 48 h after infection with wild-type Y. pestis or mutant strains. (C) Spleen bacterial burdens 48 h after inoculation with wild-type Y. pestis or mutant strains. For panels B and C, horizontal lines represent median values of data points. All mutant values were significantly different from wild-type values via Mann-Whitney test (*, P < 0.05; **, P < 0.0001). (D) Expression of genes of interest shown in panels B and C in the lung relative to broth-grown culture (data shown are from initial screen).
Identification of Y. pestis genes that contribute to pneumonic plague.
Other than the well-established type III secretion system (T3SS), very few Y. pestis virulence determinants of pneumonic plague have been identified. We predicted that mutation of ORFs demonstrating dynamic or constitutive upregulation in vivo would reveal genes that contribute to the pathogenesis of Y. pestis in the lung. To test this, we deleted each of the 38 genes/loci of interest by allelic exchange mutagenesis and evaluated each mutant strain in a mouse model of pneumonic plague. This analysis identified four genes whose deletion resulted in a greater than 1-log difference in bacterial burden in the lung and/or spleen compared to wild-type infection. Deletion of the locus YPO2349-YPO2352 had the most dramatic effect, resulting in a greater than 4-log decrease in bacterial burden in the lung and a 3-log decrease in the spleen (Fig. 1B). Deletion of the open reading frame YPO0159 resulted in a similar but less dramatic effect (Fig. 1B). Interestingly, deletion of YPO0862 had no effect on bacterial growth in the lung but resulted in a roughly 1-log decrease in colonization of the spleen (Fig. 1B and C). In contrast, deletion of YPO1501 resulted in a roughly 1-log increase in colonization of the spleen (Fig. 1C). Of the loci of interest, YPO0159 exhibited early induction relative to the later disease phase, the YPO2349-YPO2351 locus was induced later during disease, and YPO0862 was highly induced throughout the duration of infection (Fig. 1D). YPO1501 was highly induced throughout the duration of infection but also demonstrated significant upregulation early compared to the later disease phase (Fig. 1D).
In summary, using in vivo analysis of bacterial gene expression kinetics, we have identified three Y. pestis genes/loci that contribute to the pathogenesis of Y. pestis during primary pneumonic plague and one gene whose deletion results in enhanced dissemination to the bloodstream as reflected by recovery of bacteria from the spleen. Three of the four genes showing an in vivo phenotype demonstrated highly increased expression throughout the duration of infection, suggesting that this pattern of expression may be the most indicative of importance for pneumonic plague. Further delineating the functions of these genes during pulmonary infection will help to shed light on the mechanisms underlying the biphasic progression of pneumonic plague.
Deletion of ybtX alters progression into the inflammatory disease phase without affecting bacterial viability.
The ultimate goal of the transcriptional analysis was to identify genes whose deletion altered the biphasic progression of pneumonic plague. In addition to the phenotypes described above, we observed that mice inoculated with a strain harboring a deletion in the gene YPO1915 (common name ybtX) showed minimal disease symptoms at 48 hpi compared to those inoculated with wild-type Y. pestis. Whereas most animals infected with wild-type Y. pestis showed lethargy, diminished response to stimuli, and in some cases ruffled or matted fur, mice inoculated with the ΔybtX strain behaved similarly to uninfected animals. The ybtX gene, also known as irp8, is found within the high-pathogenicity island (HPI) of Y. pestis responsible for the synthesis and utilization of the siderophore yersiniabactin (Ybt), which is important for bacterial virulence during pneumonic and bubonic plague (6–8). ybtX encodes a predicted inner membrane protein with weak similarity to importers/exporters of siderophores in other bacteria and was recently shown to be a Yersinia Zn2+ importer (6, 7, 9). Transcription of ybtX was found to be highly induced in the lung throughout the duration of infection, with a greater than 100-fold increase in expression relative to broth-grown culture during three of the four time points tested (Fig. 2A). We anticipated that the near absence of disease symptoms at 48 hpi would correlate with reduced bacterial burdens in the lungs of infected animals. Surprisingly, deletion of ybtX did not alter bacterial viability in the lungs or spleens compared to mice infected with wild-type Y. pestis (Fig. 2B and C). Histopathological analysis of infected lungs at 48 hpi and 60 hpi during the proinflammatory disease phase revealed reduced inflammatory focus formation in mice infected with the ΔybtX strain compared to those infected with wild-type Y. pestis (Fig. 2D and E). Importantly, complementation of ΔybtX restored wild-type levels of inflammation in the lungs (Fig. 2D and E). All animals eventually succumbed to disease in approximately the same time frame, presumably due to the continued accumulation of bacterial burden and the onset of lethal sepsis (Fig. 2F). These results suggest that ybtX contributes to progression into the proinflammatory phase of pneumonic plague.
FIG 2 .
Infection with Y. pestis ΔybtX mutant. (A) ybtX transcription in the lung during infection. Transcription was evaluated by qRT-PCR compared to broth-grown culture. (B) Lung bacterial burdens in mice infected with wild-type Y. pestis CO92 or the Y. pestis ΔybtX mutant. (C) Spleen bacterial burdens in mice infected with wild-type Y. pestis CO92 or the Y. pestis ΔybtX mutant. Panels B and C show data from a representative experiment repeated in triplicate, where horizontal lines designate median values. (D) H&E staining of mouse lungs infected with wild-type Y. pestis, the Y. pestis ΔybtX mutant, and the complemented mutant. The image is representative of an experiment performed at least three times with a minimum of three mice per strain. (E) Total area of inflammation per lung section of infected mice. Twenty-four fields from six mice (4 fields per mouse section) per condition were analyzed to calculate average area per section using ImageJ software. Asterisks signify statistical significance by two-way analysis of variance (P < 0.005). (F) Survival of mice (n = 10) infected with wild-type, ΔybtX, or complemented ΔybtX strains. The graph is representative of an experiment repeated in triplicate. Mean time-to-death values were as follows: wild-type strain, 74 h; ΔybtX strain, 86 h; complemented ΔybtX strain, 72 h. Differences in mean time-to-death values were not statistically significant.
Infection with the ΔybtX strain implicates a key role for neutrophil chemotaxis in the progression of pneumonic plague.
Transition into the proinflammatory phase of pneumonic plague corresponds with the increased expression of proinflammatory cytokines beginning at 36 to 48 hpi (5). As infection with the ΔybtX strain showed diminished inflammation in the lungs, we hypothesized that comparing proinflammatory cytokine induction in ΔybtX mutant-infected animals with that in wild-type Y. pestis-infected animals would reveal dysregulation of key cytokines/chemokines that are important for initiating the proinflammatory disease phase. To test this, we evaluated the transcription of a panel of proinflammatory cytokines/chemokines by qRT-PCR analysis of infected lungs at 60 hpi. Transcription levels of the proinflammatory cytokines gamma interferon (IFN-γ), CXCL2, CCL3, interleukin-23 (IL-23), and tumor necrosis factor alpha (TNF-α) and the anti-inflammatory cytokine IL-10 were similar in animals infected with the ΔybtX mutant to those in animals infected with wild-type Y. pestis (Fig. 3). There was a significant decrease in the transcription of proinflammatory cytokines IL-6 and IL-17 and the chemokines CXCL1 and CCL2 in response to infection with the ΔybtX strain compared to infection with wild-type Y. pestis, indicating that these molecules may be involved in the onset of the proinflammatory phase of pneumonic plague (Fig. 3).
FIG 3 .
Cytokine expression during infection. Expression of cytokines was evaluated in the lungs of mice infected with wild-type Y. pestis CO92 (wt), the ΔybtX mutant, or the complemented mutant (comp ΔybtX) at 60 hpi compared to uninfected mice. Data shown are from two independent experiments (n = 5). Asterisks signify a significant difference for the mutant from the other two strains by two-way analysis of variance (P < 0.05).
The cytokines IL-6 and IL-17 and chemokines CXCL1 and CCL2 influence neutrophil chemotaxis during bacterial infection (10–14). Previously, we showed that depletion of host neutrophils prior to intranasal inoculation with Y. pestis dramatically reduced inflammation in the lung (15). Thus, we hypothesized that the diminished inflammatory response to infection with the ΔybtX mutant would correlate with decreased neutrophil chemotaxis to the lung. To evaluate this, we analyzed the innate immune cell populations of the bronchoalveolar lavage fluid (BALF) of mice inoculated with wild-type Y. pestis and the Y. pestis ΔybtX mutant using flow cytometry as we have previously described (15). Deletion of ybtX did not result in significant changes in levels of macrophages, dendritic cells, or inflammatory monocytes in the airways during infection (Fig. 4). In contrast, there was a significant decrease in the levels of neutrophils found in the airways of ΔybtX mutant-infected mice during the proinflammatory disease phase by 60 hpi (Fig. 4). Complementation of the ybtX deletion restored this neutrophil response to levels seen in infections with the wild-type strain (Fig. 4). In summary, infection with a Y. pestis strain lacking ybtX results in diminished neutrophil chemotaxis to the lung, indicating that ybtX is important to initiate the intense and ultimately lethal proinflammatory response during primary pneumonic plague.
FIG 4 .
Innate immune populations in the BALF during Y. pestis infection. At 48 and 60 hpi, the bronchoalveolar lavage fluid (BALF) was collected from infected mice (n = 5) and evaluated by flow cytometry to identify innate immune populations. Data are from a single representative experiment repeated at least three times. Populations examined were neutrophils, macrophages, monocytes, and dendritic cells (DC). The double asterisk indicates that the population is statistically significantly different from the other two populations (P < 0.05) per two-way analysis of variance.
ybtX contributes to inflammation during pulmonary infection with Klebsiella pneumoniae.
We next sought to determine if ybtX contributes to inflammation during infection with other bacterial pathogens, or if this phenomenon is specific to Y. pestis. Like Y. pestis, Klebsiella pneumoniae is a Gram-negative, extracellular pathogen of the Enterobacteriaceae family that causes acute pneumonia when introduced into the lungs. K. pneumoniae is a leading cause of Gram-negative bacterial nosocomial infections and is associated with high mortality rates (16–18). Importantly, some strains of K. pneumoniae also harbor a functional ybt locus, including the ybtX ORF (19, 20). To examine if ybtX plays a role in the onset of inflammation during K. pneumoniae-induced pneumonia, we evaluated pulmonary infection with a ΔybtX strain of K. pneumoniae VK148. Similar to Y. pestis, deletion of ybtX in K. pneumoniae did not alter bacterial viability in the lung (Fig. 5A) but resulted in differences in pathology during late-stage pneumonia (Fig. 5B and C). By 96 hpi, the lungs of mice inoculated with wild-type K. pneumoniae showed severe edema and loss of alveolar architecture typical of K. pneumoniae pulmonary infection (Fig. 5B). In contrast, the lungs of mice inoculated with the K. pneumoniae ΔybtX mutant showed limited observable edema with relatively intact alveolar architecture (Fig. 5B). Consistent with a decrease in pulmonary edema, lung weights from ΔybtX mutant-infected mice at 96 hpi were significantly lower than those from mice infected with wild-type K. pneumoniae (Fig. 5C). These results indicate that ybtX may contribute to the pathogenesis of severe, acute pneumonia for multiple species of bacteria harboring the ybt locus.
FIG 5 .

K. pneumoniae ΔybtX strain infection. (A) Lung bacterial burden of mice inoculated with wild-type K. pneumoniae strain VK148. Data shown are from two individual experiments; median values are indicated by horizontal lines. (B) H&E staining of mice inoculated with wild-type or ΔybtX K. pneumoniae. (C) Total lung weights of mice inoculated with wild-type or ΔybtX K. pneumoniae. The experiment was performed in duplicate with at least five mice. For panels A and C, mice that did not survive to the designated time point are represented by an “X.” The asterisk signifies a significant difference by two-way analysis of variance (P < 0.05).
DISCUSSION
In order to cause pneumonic plague, Y. pestis must adapt to two very different disease phases in the lung. The first phase involves avoiding and/or suppressing immune detection and clearance mechanisms to allow for rapid bacterial replication, while the second phase involves surviving the massive onslaught of host innate immune responses. In the work presented here, we initially sought to identify bacterial genes that demonstrated phase-specific regulation during pneumonic plague and then to test their role in the kinetics of biphasic disease progression. To this end, we analyzed the transcription of highly regulated bacterial genes in vivo throughout the course of infection. This represents an important departure from the vast majority of infection transcriptional studies; rather than evaluate a single time point, our goal was to follow the full kinetics of expression of a large number of Y. pestis genes previously shown to be differentially regulated during the proinflammatory phase (5). By using RT-PCR for all time points, we were able to assay bacterial gene expression as early as 24 hpi, when bacterial numbers are too small to yield reliable transcriptome data using microarray or RNA sequencing analysis of infected lung tissue (our unpublished results).
Our analysis identified 38 genes/loci of interest that we mutated and tested in a mouse model of pneumonic plague. From this analysis, we identified three genes for which deletion resulted in a greater than 1-log reduction of bacterial burden in the lung and/or spleen and one for which deletion resulted in enhanced dissemination to the bloodstream. The most striking phenotype was observed after deletion of the YPO2349-YPO2351 locus encoding PspC, PspB, and PspA, all key proteins of the phage-shock locus that has been characterized in detail in the enteric species Yersinia enterocolitica (21, 22). This system is part of a stress response that is essential for bacterial viability by protecting Yersinia from damage caused by mislocalization of the secretin component of the T3SS (21, 23). This is the first examination of this locus in Y. pestis and highlights its importance to Yersinia pathogenesis as well as the role that the T3SS plays during pulmonary infection.
The YPO0862 open reading frame encodes a putative protein of unknown function that has loose identity to a helicase-like transcription factor. Its deletion resulted in a roughly 1-log decrease in bacterial burden in the spleen, suggesting a defect in dissemination from the lungs or a defect in survival in the spleen. In contrast, deletion of YPO1501, predicted to encode a putative esterase, resulted in increased numbers of bacteria in the spleen. Evaluating the roles of both of these genes may help to identify factors important for dissemination of Y. pestis following lung infection. Finally, deletion of the YPO0159 open reading frame predicted to encode the nitrite transporter NirC reduced bacterial burdens in both the lung and the spleen. NirC has been shown to contribute to Salmonella virulence in macrophages; however, its role in Yersinia species is yet to be defined (24). Though their regulation changed during the progression of disease, three of the four genes shown to contribute to pathogenesis were highly induced throughout the duration of infection, indicating that this pattern of expression may be indicative of a role in disease. Further defining the role of each of these genes during infection will improve our understanding of the host-pathogen interactions that occur in the lung during primary pneumonic plague.
We observed that deletion of the ybtX gene resulted in diminished disease symptoms during the proinflammatory disease phase but had no effect on bacterial burden or dissemination. Detailed examination of pulmonary infection with the ΔybtX strain revealed reduced inflammation in the lung as demonstrated by histopathological analysis. The ybtX open reading frame is the third gene in the ybtPQXS operon located in the 36-kb high-pathogenicity island (HPI) that is nearly identical in all pathogenic Yersinia species (6, 25). With the exception of ybtD, all genes required for the regulation, synthesis, and transport of the siderophore yersiniabactin (Ybt) are carried within the HPI. Y. pestis mutants unable to transport or synthesize Ybt are attenuated in virulence models of bubonic and pneumonic plague (8). The products of the two genes immediately upstream of ybtX, ybtP and ybtQ, form an inner membrane ABC transporter necessary for the uptake of Ybt bound to iron (7). ybtS, the gene immediately downstream of ybtX, encodes a salicylate synthase required for the synthesis of Ybt (26, 27). The ybtX open reading frame is predicted to encode a hydrophobic inner membrane protein that belongs to the major facilitator superfamily (MFS) (7). Deletion of ybtX in Yersinia species has no impact on Ybt synthesis, uptake, utilization of iron in a Ybt-dependent manner, or virulence in mice (7, 28). This is somewhat surprising, as deletion of any of the other ybt genes within the HPI results in attenuated bacterial growth in the absence of iron and during infection.
Recently, YbtX was shown to be involved in the import of Zn2+ in Y. pestis (9). Bobrov et al. showed that yersiniabactin is required for growth of Y. pestis under Zn2+-deficient conditions in strains lacking the zinc acquisition locus ZnuABC and that zinc acquisition under these circumstances was dependent on yersiniabactin and YbtX (9). Our results are the first to identify a role for ybtX in disease. These results suggest a potential link between zinc in the induction of inflammatory responses in the lung during primary pneumonic plague. The anti-inflammatory effects of zinc within the airways have been known for some time, and it is understood that zinc deficiency in tissues can be highly inflammatory, particularly during infection (29–33). Thus, the role of ybtX in importing zinc may alter host immunity and contribute to inflammation within the lung.
The severely diminished host response in the lung allowed for use of the ΔybtX strain to probe the mouse model of pneumonic plague to identify key host mediators of inflammation. qRT-PCR evaluation revealed the decreased transcription of key proinflammatory cytokines IL-6 and IL-17 and the chemokines CXCL1 and CCL2 in the lungs of mice infected with ΔybtX, indicating that these cytokines and chemokines may be important to the biphasic progression of pneumonic plague. This is the first study to pinpoint cytokines/chemokines that may be of specific importance to the transition to the proinflammatory phase of pneumonic plague. IL-6 is a pleiotropic cytokine involved in the induction of fever and stimulation of acute-phase responses, as well as neutrophil production in the bone marrow (34–36). IL-6 is an established biomarker of pneumonia (37) and has been previously shown to be highly induced during pneumonic plague (4, 5). IL-17 is a proinflammatory cytokine known to be involved in host defense against a variety of microbes and is important for recruiting neutrophils to mucosal surfaces (11, 38, 39). IL-17 has been shown to be highly induced during pneumonic plague and is also speculated to be involved in cell-mediated defense against Yersinia infection (4, 5, 12, 40). The chemokine CCL2, otherwise known as MCP-1, is an important chemoattractant for monocytes, macrophages, and neutrophils to sites of inflammation (41, 42). CCL2 is highly induced during pneumonic plague, and it has been suggested that CCL2 interactions with its receptor on innate immune cells are important for defense against Y. pestis and are thus targeted for inhibition by the Yersinia T3SS (5, 43, 44). CXCL1 is a known chemoattractant of neutrophils that has been shown to be induced during Yersinia infection (45, 46). A common function of these four molecules is the recruitment of neutrophils to sites of inflammation, and their dysregulation in response to pulmonary infection with ΔybtX suggests an impaired ability to stimulate neutrophil chemotaxis to the lung. Design of treatments aimed at blocking these chemokines/cytokines, with the goal of limiting neutrophil accumulation in the lung, may aid in expanding the short time window during which antibiotic treatment is effective against pneumonic plague.
Infection with a ΔybtX strain revealed a significant and strikingly specific decrease in the number of neutrophils in the airways, indicating that YbtX is involved in initiating host responses that stimulate neutrophil migration to the lung. Previously, we showed that antibody-mediated depletion of neutrophils prior to inoculation with Y. pestis resulted in significantly diminished inflammation in the lung, ultimately attenuating pneumonia without altering bacterial survival (15). Here, we demonstrate deletion of a bacterial gene that results in a similar effect. Together, these data highlight that the pathology of pneumonic plague is largely host mediated, the consequence of recruitment of neutrophils to the lung and their continued accumulation in the airways. Further, this response does not appear to be dependent solely on a threshold of bacterial burden in the lung, as deletion of ybtX attenuated host inflammatory responses without affecting bacterial burden. The unchanged bacterial burdens in the lung and spleen despite a severely hindered neutrophil response indicate that neutrophils play a limited role in controlling Y. pestis during pulmonary infection and are thus highly damaging to the host without any immediately obvious benefit. Therefore, the ability of Y. pestis to resist neutrophil-mediated killing is likely key to the progression of pneumonic plague.
Deletion of ybtX also altered infection with K. pneumoniae, resulting in decreased inflammation as indicated by histopathological examination and decrease in lung weight compared to wild-type-infected lungs. K. pneumoniae also causes severe acute pneumonia, albeit via different mechanisms. Infection with K. pneumoniae leads to early inflammatory responses in the lung that ultimately result in severe edema and a near-complete loss of alveolar architecture in localized areas in the lung. The finding that ybtX contributes to this response is intriguing and indicates that its function may be conserved among a number of bacterial species that cause pneumonia and carry the ybt gene locus. This is important, as evaluating the role of ybtX may help to elucidate the mechanisms that contribute to the onset of severe pneumonia caused by multiple pathogens and may represent a point for therapeutic targeting.
MATERIALS AND METHODS
Bacterial strains and culture conditions.
The fully virulent Yersinia pestis strain CO92 was obtained from the U.S. Army, Fort Detrick, MD. Y. pestis strains were grown on brain heart infusion (BHI) agar (Difco Laboratories) at 26°C for 2 days. For infections, liquid cultures of Y. pestis CO92 were grown in BHI broth for 6 to 12 h at 26°C. The cultures were then diluted to an optical density at 620 nm (OD620) of 0.05 to 0.1 in BHI supplemented with 2.5 mM CaCl2 and grown for 12 to 16 h at 37°C with constant shaking.
VK148, a streptomycin- and rifampin-resistant mutant of K. pneumoniae ATCC 43816, was grown on LB agar with 30 µg/ml rifampin at 26°C for 24 h. For infections, a liquid culture of K. pneumoniae was grown in LB broth overnight at 37°C.
Deletion and complementation of ybtX.
For Y. pestis, the ybtX open reading frame was deleted using a modified form of lambda red recombination described by Lathem et al. (47). Briefly, upstream and downstream sequences of ybtX were amplified and combined in splicing by overhang extension (SOE) PCRs with a Kanr cassette flanked by FLP recombination target (FRT) sites (48) for allelic replacement of the wild-type ybtX ORF. The Kanr cassette was resolved by the introduction of pSkippy, a Tets derivative of pFLP3 (49) harboring an Ampr cassette and sacB and carrying the FLP recombinase gene under the control of the lac promoter.
A complementing strain for ΔybtX was constructed by using Tn7-based integration of the ybtX open reading frame under the control of the ybtPQXS promoter in single copy into the chromosomal glmS-pstS intergenic region. Briefly, the ybtX open reading frame was cloned immediately downstream of the ybtPQXS promoter in the multiple-cloning site of pUC18R6K-mini-Tn7T-Kan (49). The resulting plasmid was electroporated along with pTNS2 (49), a plasmid carrying the TnsABC+D specific transposition pathway, into the ΔybtX strain, and transformants were selected on BHI plates containing kanamycin. The Kanr cassette was then resolved via the introduction of pSkippy as described above.
For K. pneumoniae, the ybtX open reading frame was deleted using double recombination as previously described (50). Briefly, approximately 1-kb upstream and downstream flanking regions of the ybtX gene were PCR amplified and combined using SOE PCR for cloning into the pKAS46 vector. The resulting vector was mated into K. pneumoniae, and merodiploids were selected on LB agar with rifampin (30 µg/ml) and kanamycin (50 µg/ml). Merodiploids were grown in LB broth without antibiotics for ~4 h and then plated on LB agar with streptomycin (1 mg/ml). Kanamycin-susceptible colonies were tested by colony PCR for loss of the ybtX gene before sequencing to confirm deletion.
Animals and animal infections.
All animal studies were approved by the University of North Carolina at Chapel Hill Office of Animal Care and Use, protocol 09-057. Six- to 8-week-old female C57BL/6J mice were obtained from Jackson Laboratories. Mice were provided with food and water ad libitum and maintained at 25°C and 15% humidity with alternating 12-h periods of light and dark. For animal infections, groups of four to five mice were lightly anesthetized with ketamine-xylazine and inoculated intranasally with a lethal dose of bacteria suspended in 20 µl phosphate-buffered saline (PBS); a dose of 104 CFU was used for Y. pestis and 105 was used for K. pneumoniae. Moribund animals were euthanized with an overdose of sodium pentobarbital. For determination of bacterial burden, lungs or spleens were removed at the indicated times and homogenized in 1 ml PBS using an Omni Tissue Tearer. Serial dilutions of each organ homogenate were plated on BHI agar (for Y. pestis) or LB agar with rifampin (30 µg/ml, for K. pneumoniae) and reported as CFU/organ.
Survival curves.
For analysis of survival kinetics, mice were inoculated with 104 CFU of Y. pestis CO92 or ΔybtX mutant. Mice were monitored twice daily and were euthanized with an overdose of sodium pentobarbital when moribund. Remaining mice were euthanized at the termination of the experiment.
Histopathology.
Groups of three to four mice were inoculated intranasally as described above, and lungs were inflated with 1 ml of 10% neutral buffered formalin via tracheal cannulation and then removed and incubated in 10% formalin for a minimum of 24 h. Lungs were washed once in PBS for 2 h, immersed in 70% ethyl alcohol (EtOH), and embedded in paraffin. Three 5-micrometer sections 200 µm apart per lung were stained with hematoxylin-eosin (H&E) for examination.
For quantitation of histopathology, four images were taken at ×4 magnification of a single H&E-stained lung section from each of six animals (from two independent experiments) infected with either wild-type Y. pestis, Y. pestis ΔybtX mutant, or complemented Y. pestis ΔybtX mutant at 48 and 60 hpi. Inflammatory foci were encircled, and pixel area was measured using ImageJ software (at ×4 magnification; 5.48 pixels = 10 µm). The 24 fields per condition (infecting strain and time point) were averaged to yield the average area of inflammation per mouse section.
Analysis of bacterial gene expression in vivo.
In order to evaluate Y. pestis gene expression in the lungs of infected mice, two identical experiments were performed as follows: groups of mice were inoculated intranasally with 1 × 104 CFU of Y. pestis CO92, and at 24, 36, 48, and 60 h, lungs were harvested from five mice, submerged immediately in 10 ml of RNAlater solution (Ambion), and stored at 4°C for 24 h. Lungs were then transferred to 10 ml TRIzol and homogenized with an Omni Tissue Tearer. Total RNA was then isolated per the manufacturer’s instructions and treated with DNase I (Ambion). For an in vitro sample for comparison, total RNA was also isolated from 1 ml Y. pestis culture grown for 16 h at 37°C in the presence of 2.5 mM CaCl2. Five micrograms of RNA was then used to generate cDNA using the Superscript III polymerase (Invitrogen) along with genome-directed primers specific for DNA upstream of each Y. pestis CO92 ORF (Washington University sequencing facility). cDNAs were then used as the templates for amplification and detection of the 288 Y. pestis target genes with SYBR green dye (Bio-Rad) in an iCycler thermocycler (Bio-Rad). For each gene, the calculated threshold cycle (CT) was normalized to the CT of the gyrB gene from the same sample before calculating fold change relative to sample isolated from broth-grown culture using the ΔΔCT method (51, 52).
Cytokine analysis.
Groups of five mice were inoculated intranasally with 1 × 104 CFU of Y. pestis CO92, Y. pestis CO92 ΔybtX, or the complemented Y. pestis CO92 ΔybtX. Uninfected mice and mice infected for 24, 48, and 60 h were sacrificed, and the lungs were removed, immediately minced, and submerged in 2 ml of TRIzol reagent (Ambion). Lungs were then homogenized with an Omni Tissue Tearer. Total RNA was purified from lung homogenates using the TRIzol reagent manufacturer protocol, treated with Turbo DNase (Ambion), and reverse transcribed with the iScript cDNA synthesis kit (Bio-Rad) according to the manufacturer’s instructions. cDNAs were used as the templates for amplification and detection of the mouse genes encoding IL-17, IL-6, IL-23, TNF-α, IFN-γ, CCL2, CCL3, CXCL1, CXCL2, IL-10, and IL-12 and with SYBR green dye (Bio-Rad) in an iCycler thermocycler (Bio-Rad). For each gene, the calculated threshold cycle (CT) was normalized to that of glyceraldehyde-3-phosphate dehydrogenase (GAPDH) from the same sample prior to calculating the fold change using the ΔΔCT method (51, 52).
Lavage of lungs for flow cytometry.
For generating a lung single-cell suspension of the BALF, mice were euthanized with an overdose of sodium pentobarbital, and the hepatic portal vein was cut and bled. The tracheas were cannulated with a 22-gauge catheter, and lungs were inflated with 1 ml PBS using a 1-ml syringe, which was then drawn out slowly. This was repeated twice for a total of 3 ml. BALF suspensions were spun at 500 × g for 5 min at 4°C and then resuspended in 1 ml red blood cell lysis solution (0.15 M NH4Cl, 10 mM KHCO3, 0.1 mM EDTA). After incubation at room temperature for 1 min, 9 ml PBS was added and cells were pelleted as described above for staining.
Staining of lung cell suspensions for flow cytometry.
After red blood cell lysis, cell suspensions from each animal were resuspended in 100 µl of 2.4G2 hybridoma supernatant and incubated at room temperature for 20 min to block macrophage Fc receptors. Cell suspensions were then pelleted at 500 × g for 5 min at 4°C. Cells were resuspended and incubated for 30 min at 4°C with the following fluorescently labeled antibodies in flow cytometry buffer (2% fetal bovine serum in PBS) for staining of cell surface markers (1:500 dilutions): CD11b-phycoerythrin (clone M1/70.15; Invitrogen), CD11c-phycoerythrin-Texas Red (clone N418; Invitrogen), Ly-6G-phycoerythrin-Cy7 (clone 1A8; BD Bioscience), LIVE/DEAD fixable aqua dead cell stain (clone L34957; Invitrogen), and F4/80-allophycocyanin (clone BM8; BioLegend). Stained cells were analyzed based on fluorescence staining patterns to identify alveolar macrophages (F4/80+ CD11bmid/low CD11chigh), CD11bhigh interstitial/exudate macrophages (F4/80+ CD11bhigh CD11clow/mid), monocytes (F4/80− CD11bhigh CD11clow Ly-6G−), CD11bhigh and CD11blow dendritic cells (F4/80− CD11chigh CD11bhigh or low), and neutrophils (F4/80− CD11clow CD11bhigh Ly-6G+) (15). Five hundred microliters of PBS was then added to samples, followed by centrifugation at 500 × g at 4°C. Cell suspensions were then resuspended in 2% formalin and incubated at room temperature for 15 min for fixation, followed by centrifugation and resuspension in PBS with gentamicin (100 µg/ml) for removal from the biosafety level 3 laboratory.
SUPPLEMENTAL MATERIAL
Y. pestis genes with expression patterns of interest during lung infection
ACKNOWLEDGMENTS
This work was supported by National Institutes of Health (NIH) grants AI057157 and AI099698, as well as NIH National Research Service award AI085830. The UNC Flow Cytometry Core Facility is supported in part by an NCI Center Core Support grant (P30CA016086) to the UNC Lineberger Comprehensive Cancer Center.
We thank the UNC Center for Gastrointestinal Biology and Disease Histopathology Core Facility for tissue processing and staining and the UNC Microbiology and Immunology Flow Cytometry Core Facility for equipment and training.
Footnotes
Citation Pechous RD, Broberg CA, Stasulli NM, Miller VL, Goldman WE. 2015. In vivo transcriptional profiling of Yersinia pestis reveals a novel bacterial mediator of pulmonary inflammation. mBio 6(1):e02302-14. doi:10.1128/mBio.02302-14.
REFERENCES
- 1.Inglesby TV, Dennis DT, Henderson DA, Bartlett JG, Ascher MS, Eitzen E, Fine AD, Friedlander AM, Hauer J, Koerner JF, Layton M, McDade J, Osterholm MT, O’Toole T, Parker G, Perl TM, Russell PK, Schoch-Spana M, Tonat K. 2000. Plague as a biological weapon: medical and public health management. Working Group on Civilian Biodefense. JAMA 283:2281–2290. doi: 10.1001/jama.283.17.2281. [DOI] [PubMed] [Google Scholar]
- 2.Agar SL, Sha J, Foltz SM, Erova TE, Walberg KG, Baze WB, Suarez G, Peterson JW, Chopra AK. 2009. Characterization of the rat pneumonic plague model: infection kinetics following aerosolization of Yersinia pestis CO92. Microbes Infect 11:205–214. doi: 10.1016/j.micinf.2008.11.009. [DOI] [PubMed] [Google Scholar]
- 3.Agar SL, Sha J, Foltz SM, Erova TE, Walberg KG, Parham TE, Baze WB, Suarez G, Peterson JW, Chopra AK. 2008. Characterization of a mouse model of plague after aerosolization of Yersinia pestis CO92. Microbiology 154:1939–1948. doi: 10.1099/mic.0.2008/017335-0. [DOI] [PubMed] [Google Scholar]
- 4.Bubeck SS, Cantwell AM, Dube PH. 2007. Delayed inflammatory response to primary pneumonic plague occurs in both outbred and inbred mice. Infect Immun 75:697–705. doi: 10.1128/IAI.00403-06. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Lathem WW, Crosby SD, Miller VL, Goldman WE. 2005. Progression of primary pneumonic plague: a mouse model of infection, pathology, and bacterial transcriptional activity. Proc Natl Acad Sci U S A 102:17786–17791. doi: 10.1073/pnas.0506840102. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Perry RD, Fetherston JD. 2011. Yersiniabactin iron uptake: mechanisms and role in Yersinia pestis pathogenesis. Microbes Infect 13:808–817. doi: 10.1016/j.micinf.2011.04.008. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Fetherston JD, Bertolino VJ, Perry RD. 1999. YbtP and YbtQ: two ABC transporters required for iron uptake in Yersinia pestis. Mol Microbiol 32:289–299. doi: 10.1046/j.1365-2958.1999.01348.x. [DOI] [PubMed] [Google Scholar]
- 8.Fetherston JD, Kirillina O, Bobrov AG, Paulley JT, Perry RD. 2010. The yersiniabactin transport system is critical for the pathogenesis of bubonic and pneumonic plague. Infect Immun 78:2045–2052. doi: 10.1128/IAI.01236-09. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Bobrov AG, Kirillina O, Fetherston JD, Miller MC, Burlison JA, Perry RD. 2014. The Yersinia pestis siderophore, yersiniabactin, and the ZnuABC system both contribute to zinc acquisition and the development of lethal septicemic plague in mice. Mol Microbiol 93:759–775. doi: 10.1111/mmi.12693. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Kobayashi Y. 2008. The role of chemokines in neutrophil biology. Front Biosci 13:2400–2407. doi: 10.2741/2853. [DOI] [PubMed] [Google Scholar]
- 11.Iwakura Y, Nakae S, Saijo S, Ishigame H. 2008. The roles of IL-17A in inflammatory immune responses and host defense against pathogens. Immunol Rev 226:57–79. doi: 10.1111/j.1600-065X.2008.00699.x. [DOI] [PubMed] [Google Scholar]
- 12.Lin J-S, Kummer LW, Szaba FM, Smiley ST. 2011. IL-17 contributes to cell-mediated defense against pulmonary Yersinia pestis infection. J Immunol 186:1675–1684. doi: 10.4049/jimmunol.1003303. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Cua DJ, Tato CM. 2010. Innate IL-17-producing cells: the sentinels of the immune system. Nat Rev Immunol 10:479–489. doi: 10.1038/nri2800. [DOI] [PubMed] [Google Scholar]
- 14.Xu S, Cao X. 2010. Interleukin-17 and its expanding biological functions. Cell Mol Immunol 7:164–174. doi: 10.1038/cmi.2010.21. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Pechous RD, Sivaraman V, Price PA, Stasulli NM, Goldman WE. 2013. Early host cell targets of Yersinia pestis during primary pneumonic plague. PLoS Pathog. 9:e1003679. doi: 10.1371/journal.ppat.1003679. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Di Martino P, Bertin Y, Girardeau JP, Livrelli V, Joly B, Darfeuille-Michaud A. 1995. Molecular characterization and adhesive properties of CF29K, an adhesin of Klebsiella pneumoniae strains involved in nosocomial infections. Infect Immun 63:4336–4344. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Hasdemir UO, Chevalier J, Nordmann P, Pagès J-M. 2004. Detection and prevalence of active drug efflux mechanism in various multidrug-resistant Klebsiella pneumoniae strains from Turkey. J Clin Microbiol 42:2701–2706. doi: 10.1128/JCM.42.6.2701-2706.2004. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Broberg CA, Palacios M, Miller VL. 2014. Klebsiella: a long way to go towards understanding this enigmatic jet-setter. F1000Prime Rep 6:64. doi: 10.12703/P6-64. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Lawlor MS, O’Connor C, Miller VL. 2007. Yersiniabactin is a virulence factor for Klebsiella pneumoniae during pulmonary infection. Infect Immun 75:1463–1472. doi: 10.1128/IAI.00372-06. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Carniel E. 2001. The Yersinia high-pathogenicity island: an iron-uptake island. Microbes Infect 3:561–569. doi: 10.1016/S1286-4579(01)01412-5. [DOI] [PubMed] [Google Scholar]
- 21.Darwin AJ. 2005. The phage-shock-protein response. Mol Microbiol 57:621–628. doi: 10.1111/j.1365-2958.2005.04694.x. [DOI] [PubMed] [Google Scholar]
- 22.Darwin AJ, Miller VL. 2001. The psp locus of Yersinia enterocolitica is required for virulence and for growth in vitro when the Ysc type III secretion system is produced. Mol Microbiol 39:429–444. doi: 10.1046/j.1365-2958.2001.02235.x. [DOI] [PubMed] [Google Scholar]
- 23.Darwin AJ. 2013. Stress relief during host infection: the phage shock protein response supports bacterial virulence in various ways. PLoS Pathog. 9:e1003388. doi: 10.1371/journal.ppat.1003388. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Das P, Lahiri A, Lahiri A, Chakravortty D. 2009. Novel role of the nitrite transporter NirC in salmonella pathogenesis: SPI2-dependent suppression of inducible nitric oxide synthase in activated macrophages. Microbiology 155:2476–2489. doi: 10.1099/mic.0.029611-0. [DOI] [PubMed] [Google Scholar]
- 25.Forman S, Paulley JT, Fetherston JD, Cheng YQ, Perry RD. 2010. Yersinia ironomics: comparison of iron transporters among Yersinia pestis biotypes and its nearest neighbor, Yersinia pseudotuberculosis. Biometals 23:275–294. doi: 10.1007/s10534-009-9286-4. [DOI] [PubMed] [Google Scholar]
- 26.Miller MC, Fetherston JD, Pickett CL, Bobrov AG, Weaver RH, DeMoll E, Perry RD. 2010. Reduced synthesis of the Ybt siderophore or production of aberrant Ybt-like molecules activates transcription of yersiniabactin genes in Yersinia pestis. Microbiology 156:2226–2238. doi: 10.1099/mic.0.037945-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Gehring AM, DeMoll E, Fetherston JD, Mori I, Mayhew GF, Blattner FR, Walsh CT, Perry RD. 1998. Iron acquisition in plague: modular logic in enzymatic biogenesis of yersiniabactin by Yersinia pestis. Chem Biol 5:573–586. doi: 10.1016/S1074-5521(98)90115-6. [DOI] [PubMed] [Google Scholar]
- 28.Brem D, Pelludat C, Rakin A, Jacobi CA, Heesemann J. 2001. Functional analysis of yersiniabactin transport genes of Yersinia enterocolitica. Microbiology 147:1115–1127. [DOI] [PubMed] [Google Scholar]
- 29.Bao S, Liu M-J, Lee B, Besecker B, Lai J-P, Guttridge DC, Knoell DL. 2010. Zinc modulates the innate immune response in vivo to polymicrobial sepsis through regulation of NF-kappaB. Am J Physiol Lung Cell Mol Physiol 298:L744–L754. doi: 10.1152/ajplung.00368.2009. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Prasad AS. 2009. Zinc: role in immunity, oxidative stress and chronic inflammation. Curr Opin Clin Nutr Metab Care 12:646–652. doi: 10.1097/MCO.0b013e3283312956. [DOI] [PubMed] [Google Scholar]
- 31.Liu M-J, Bao S, Napolitano JR, Burris DL, Yu L, Tridandapani S, Knoell DL. 2014. Zinc regulates the acute phase response and serum amyloid A production in response to sepsis through JAK-STAT3 signaling. PLoS One 9:e94934. doi: 10.1371/journal.pone.0094934. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Lang C, Murgia C, Leong M, Tan L-W, Perozzi G, Knight D, Ruffin R, Zalewski P. 2007. Anti-inflammatory effects of zinc and alterations in zinc transporter mRNA in mouse models of allergic inflammation. Am J Physiol Lung Cell Mol Physiol 292:L577–L584. doi: 10.1152/ajplung.00280.2006. [DOI] [PubMed] [Google Scholar]
- 33.Liu M-J, Bao S, Gálvez-Peralta M, Pyle CJ, Rudawsky AC, Pavlovicz RE, Killilea DW, Li C, Nebert DW, Wewers MD, Knoell DL. 2013. ZIP8 regulates host defense through zinc-mediated inhibition of NF-κB. Cell Rep 3:386–400. doi: 10.1016/j.celrep.2013.01.009. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Montón C, Torres A. 1998. Lung inflammatory response in pneumonia. Monaldi Arch Chest Dis 53:56–63. [PubMed] [Google Scholar]
- 35.Kopf M, Baumann H, Freer G, Freudenberg M, Lamers M, Kishimoto T, Zinkernagel R, Bluethmann H, Köhler G. 1994. Impaired immune and acute-phase responses in interleukin-6-deficient mice. Nature 368:339–342. doi: 10.1038/368339a0. [DOI] [PubMed] [Google Scholar]
- 36.Bernad A, Kopf M, Kulbacki R, Weich N, Koehler G, Gutierrez-Ramos JC. 1994. Interleukin-6 is required in vivo for the regulation of stem cells and committed progenitors of the hematopoietic system. Immunity 1:725–731. doi: 10.1016/S1074-7613(94)80014-6. [DOI] [PubMed] [Google Scholar]
- 37.Christ-Crain M, Opal SM. 2010. Clinical review: the role of biomarkers in the diagnosis and management of community-acquired pneumonia. Crit Care 14:203. doi: 10.1186/cc8155. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Aujla SJ, Dubin PJ, Kolls JK. 2007. Th17 cells and mucosal host defense. Semin Immunol 19:377–382. doi: 10.1016/j.smim.2007.10.009. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Reynolds JM, Angkasekwinai P, Dong C. 2010. IL-17 family member cytokines: regulation and function in innate immunity. Cytokine Growth Factor Rev 21:413–423. doi: 10.1016/j.cytogfr.2010.10.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Parent MA, Berggren KN, Kummer LW, Wilhelm LB, Szaba FM, Mullarky IK, Smiley ST. 2005. Cell-mediated protection against pulmonary Yersinia pestis infection. Infect Immun 73:7304–7310. doi: 10.1128/IAI.73.11.7304-7310.2005. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Serbina NV, Jia T, Hohl TM, Pamer EG. 2008. Monocyte-mediated defense against microbial pathogens. Annu Rev Immunol 26:421–452. doi: 10.1146/annurev.immunol.26.021607.090326. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42.Johnston B, Burns AR, Suematsu M, Issekutz TB, Woodman RC, Kubes P. 1999. Chronic inflammation upregulates chemokine receptors and induces neutrophil migration to monocyte chemoattractant protein-1. J Clin Invest 103:1269–1276. doi: 10.1172/JCI5208. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43.Peters KN, Dhariwala MO, Hughes Hanks JM, Brown CR, Anderson DM. 2013. Early apoptosis of macrophages modulated by injection of Yersinia pestis YopK promotes progression of primary pneumonic plague. PLoS Pathog 9:e1003324. doi: 10.1371/journal.ppat.1003324. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44.Koster F, Perlin DS, Park S, Brasel T, Gigliotti A, Barr E, Myers L, Layton RC, Sherwood R, Lyons CR. 2010. Milestones in progression of primary pneumonic plague in cynomolgus macaques. Infect Immun 78:2946–2955. doi: 10.1128/IAI.01296-09. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45.Uittenbogaard AM, Chelvarajan RL, Myers-Morales T, Gorman AA, Brickey WJ, Ye Z, Kaplan AM, Cohen DA, Ting JP, Straley SC. 2012. Toward a molecular pathogenic pathway for Yersinia pestis YopM. Front Cell Infect Microbiol 2:155. doi: 10.3389/fcimb.2012.00155. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46.Demeure CE, Blanchet C, Fitting C, Fayolle C, Khun H, Szatanik M, Milon G, Panthier J-J, Jaubert J, Montagutelli X, Huerre M, Cavaillon J-M, Carniel E. 2012. Early systemic bacterial dissemination and a rapid innate immune response characterize genetic resistance to plague of SEG mice. J Infect Dis 205:134–143. doi: 10.1093/infdis/jir696. [DOI] [PubMed] [Google Scholar]
- 47.Lathem WW, Price PA, Miller VL, Goldman WE. 2007. A plasminogen-activating protease specifically controls the development of primary pneumonic plague. Science 315:509–513. doi: 10.1126/science.1137195. [DOI] [PubMed] [Google Scholar]
- 48.Datsenko KA, Wanner BL. 2000. One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products. Proc Natl Acad Sci U S A 97:6640–6645. doi: 10.1073/pnas.120163297. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49.Choi K-H, Gaynor JB, White KG, Lopez C, Bosio CM, Karkhoff-Schweizer RR, Schweizer HP. 2005. A Tn7-based broad-range bacterial cloning and expression system. Nat Methods 2:443–448. doi: 10.1038/nmeth765. [DOI] [PubMed] [Google Scholar]
- 50.Skorupski K, Taylor RK. 1996. Positive selection vectors for allelic exchange. Gene 169:47–52. doi: 10.1016/0378-1119(95)00793-8. [DOI] [PubMed] [Google Scholar]
- 51.Livak KJ, Schmittgen TD. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25:402–408. doi: 10.1006/meth.2001.1262. [DOI] [PubMed] [Google Scholar]
- 52.Applied Biosystems. 1997. User bulletin #2. ABI Prism 7700 Sequence Detection System. Applied Biosystems, Foster City, CA. [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Y. pestis genes with expression patterns of interest during lung infection




